Hot Stocks
Monday, September 12, 2016
U.S. Senate committee chair: Mylan's response on EpiPen price hike 'incomplete'
WASHINGTON, Sept 9 (Reuters) - The chairman of the U.S.
Senate Judiciary Committee probing Mylan NV's EpiPen
price hike on Friday said its response to his query was
"incomplete," and called on the...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment